Search

Search Results
Results 6271 - 6280 of 8666 for Skin Cancer
  • Gilenya
    Drug - 18 Jun 2026
    Consumer Medicine Information (CMI) about Gilenya intended for persons living in Australia.
  • Filosir
    Drug - 18 Jun 2026
    Consumer Medicine Information (CMI) about Filosir intended for persons living in Australia.
  • Itracap
    Drug - 1 Jun 2026
    Consumer Medicine Information (CMI) about Itracap intended for persons living in Australia.
  • Vidaza
    Drug - 7 May 2026
    Consumer Medicine Information (CMI) about Vidaza intended for persons living in Australia.
  • Revestive
    Drug - 4 May 2026
    Consumer Medicine Information (CMI) about Revestive intended for persons living in Australia.
  • Lipid nanoparticles in drug delivery
    White Paper - 30 Apr 2026
    Lipid nanoparticles address key drug delivery challenges, including immune evasion, toxicity, and regulatory approval.
  • Study identifies protein essential for repairing damage after inflammation
    News - 28 Apr 2026
    Whenever there is a wound or infection, the body produces an inflammatory response. This is the body's first line of defense, and macrophages — cells of the innate immune system — play a key role:...
  • Pinecone-inspired conduit enables suture-free repair of nerve injuries
    News - 21 Apr 2026
    As the authors detail, PNI is a prevalent neurological condition that often causes permanent sensory and motor dysfunction, severely impairing patient's quality of life.
  • Karvezide
    Drug - 20 Apr 2026
    Consumer Medicine Information (CMI) about Karvezide intended for persons living in Australia.
  • Avapro HCT
    Drug - 20 Apr 2026
    Consumer Medicine Information (CMI) about Avapro HCT intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback